Correlation Between Neurocrine Biosciences and Fomo Worldwide

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Fomo Worldwide at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Fomo Worldwide into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Fomo Worldwide, you can compare the effects of market volatilities on Neurocrine Biosciences and Fomo Worldwide and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Fomo Worldwide. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Fomo Worldwide.

Diversification Opportunities for Neurocrine Biosciences and Fomo Worldwide

-0.5

Correlation Coefficient

Neurocrine Biosciences  Fomo Worldwide

Very good diversification

The 3 months correlation between Neurocrine and Fomo is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Fomo Worldwide in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fomo Worldwide and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Fomo Worldwide. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fomo Worldwide has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Fomo Worldwide go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Fomo Worldwide

Given the investment horizon of 90 days Neurocrine Biosciences is expected to under-perform the Fomo Worldwide. But the stock apears to be less risky and, when comparing its historical volatility, Neurocrine Biosciences is 64.61 times less risky than Fomo Worldwide. The stock trades about -0.09 of its potential returns per unit of risk. The Fomo Worldwide is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Fomo Worldwide on December 26, 2024 and sell it today you would earn a total of  0.01  from holding Fomo Worldwide or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Fomo Worldwide

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Fomo Worldwide

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Fomo Worldwide are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Fomo Worldwide unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Fomo Worldwide

The main advantage of trading using opposite Neurocrine Biosciences and Fomo Worldwide positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Fomo Worldwide can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fomo Worldwide will offset losses from the drop in Fomo Worldwide's long position.

The idea behind Neurocrine Biosciences and Fomo Worldwide pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.